Review of candidate vaccines for the prevention of Lassa fever

التفاصيل البيبلوغرافية
العنوان:	Review of candidate vaccines for the prevention of Lassa fever
المؤلفون:	O. D. Popova, O. V. Zubkova, T. A. Ozharovskaia, D. I. Zrelkin, D. V. Voronina, I. V. Dolzhikova, D. V. Shcheblyakov, B. S. Naroditsky, D. Yu. Logunov, A. L. Gintsburg
المصدر:	Вопросы вирусологии, Vol 66, Iss 2, Pp 91-102 (2021)
بيانات النشر:	Central Research Institute for Epidemiology, 2021.
سنة النشر:	2021
المجموعة:	LCC:Microbiology
مصطلحات موضوعية:	lassa virus, candidate vaccines, recombinant vaccines, recombinant viral vectors, Microbiology, QR1-502
الوصف:	The Lassa virus one of the main etiological agent of hemorrhagic fevers in the world: according to WHO estimates, it affects 100,000 to 300,000 people annually, which results in up to 10,000 deaths [1]. Although expansion of Lassa fever caused by this pathogen is mostly limited to the West African countries: Sierra Leone, Liberia, Guinea and Nigeria, imported cases have been historically documented in Europe, the United States of America (USA), Canada, Japan, and Israel [2]. In 2017, WHO included the Lassa virus in the list of priority pathogens in need of accelerated research, development of vaccines, therapeutic agents and diagnostic tools regarding infections they cause [3]. This review describes main technological platforms used for the development of vaccines for the prevention of Lassa fever.
نوع الوثيقة:	article
وصف الملف:	electronic resource
اللغة:	English Russian
تدمد:	0507-4088 2411-2097
العلاقة:	https://virusjour.crie.ru/jour/article/viewFile/493/308Test; https://doaj.org/toc/0507-4088Test; https://doaj.org/toc/2411-2097Test
DOI:	10.36233/0507-4088-33
الوصول الحر:	https://doaj.org/article/8712d4df58614c4692a44a0e8aff11f6Test
رقم الانضمام:	edsdoj.8712d4df58614c4692a44a0e8aff11f6
قاعدة البيانات:	Directory of Open Access Journals

View record in DOAJ

الوصف
تدمد:	05074088 24112097
DOI:	10.36233/0507-4088-33